nodes	percent_of_prediction	percent_of_DWPC	metapath
Eprosartan—ABCC2—epilepsy syndrome	0.322	1	CbGaD
Eprosartan—ABCC2—Levetiracetam—epilepsy syndrome	0.1	0.237	CbGbCtD
Eprosartan—ABCC2—Carbamazepine—epilepsy syndrome	0.0575	0.136	CbGbCtD
Eprosartan—ABCC2—Phenytoin—epilepsy syndrome	0.0516	0.122	CbGbCtD
Eprosartan—ABCC2—Phenobarbital—epilepsy syndrome	0.046	0.109	CbGbCtD
Eprosartan—CYP2C9—Trimethadione—epilepsy syndrome	0.0286	0.0676	CbGbCtD
Eprosartan—CYP2C9—Fosphenytoin—epilepsy syndrome	0.0269	0.0635	CbGbCtD
Eprosartan—CYP2C9—Carbamazepine—epilepsy syndrome	0.0193	0.0456	CbGbCtD
Eprosartan—CYP2C9—Primidone—epilepsy syndrome	0.018	0.0426	CbGbCtD
Eprosartan—CYP2C9—Phenytoin—epilepsy syndrome	0.0173	0.0409	CbGbCtD
Eprosartan—CYP2C9—Propofol—epilepsy syndrome	0.0162	0.0382	CbGbCtD
Eprosartan—CYP2C9—Phenobarbital—epilepsy syndrome	0.0154	0.0365	CbGbCtD
Eprosartan—CYP2C9—Diazepam—epilepsy syndrome	0.0146	0.0346	CbGbCtD
Eprosartan—CYP2C9—Valproic Acid—epilepsy syndrome	0.0115	0.0273	CbGbCtD
Eprosartan—Losartan—CYP2C19—epilepsy syndrome	0.000352	0.48	CrCbGaD
Eprosartan—Losartan—ALB—epilepsy syndrome	0.000195	0.266	CrCbGaD
Eprosartan—Losartan—ABCB1—epilepsy syndrome	0.000186	0.254	CrCbGaD
Eprosartan—Rash—Fosphenytoin—epilepsy syndrome	5.96e-05	0.00031	CcSEcCtD
Eprosartan—Dermatitis—Fosphenytoin—epilepsy syndrome	5.95e-05	0.000309	CcSEcCtD
Eprosartan—Nervousness—Gabapentin—epilepsy syndrome	5.95e-05	0.000309	CcSEcCtD
Eprosartan—Asthenia—Clonazepam—epilepsy syndrome	5.94e-05	0.000309	CcSEcCtD
Eprosartan—Rhinitis—Topiramate—epilepsy syndrome	5.93e-05	0.000308	CcSEcCtD
Eprosartan—Back pain—Gabapentin—epilepsy syndrome	5.92e-05	0.000308	CcSEcCtD
Eprosartan—Headache—Fosphenytoin—epilepsy syndrome	5.92e-05	0.000308	CcSEcCtD
Eprosartan—Thrombocytopenia—Valproic Acid—epilepsy syndrome	5.9e-05	0.000307	CcSEcCtD
Eprosartan—Palpitations—Pregabalin—epilepsy syndrome	5.9e-05	0.000307	CcSEcCtD
Eprosartan—Asthenia—Phenytoin—epilepsy syndrome	5.9e-05	0.000307	CcSEcCtD
Eprosartan—Nausea—Midazolam—epilepsy syndrome	5.89e-05	0.000306	CcSEcCtD
Eprosartan—Muscle spasms—Gabapentin—epilepsy syndrome	5.89e-05	0.000306	CcSEcCtD
Eprosartan—Tachycardia—Valproic Acid—epilepsy syndrome	5.89e-05	0.000306	CcSEcCtD
Eprosartan—Diarrhoea—Zonisamide—epilepsy syndrome	5.88e-05	0.000305	CcSEcCtD
Eprosartan—Pharyngitis—Topiramate—epilepsy syndrome	5.88e-05	0.000305	CcSEcCtD
Eprosartan—Loss of consciousness—Pregabalin—epilepsy syndrome	5.87e-05	0.000305	CcSEcCtD
Eprosartan—Asthenia—Oxcarbazepine—epilepsy syndrome	5.87e-05	0.000305	CcSEcCtD
Eprosartan—Pruritus—Clonazepam—epilepsy syndrome	5.86e-05	0.000304	CcSEcCtD
Eprosartan—Vomiting—Vigabatrin—epilepsy syndrome	5.86e-05	0.000304	CcSEcCtD
Eprosartan—Oedema peripheral—Topiramate—epilepsy syndrome	5.83e-05	0.000303	CcSEcCtD
Eprosartan—Hyperhidrosis—Valproic Acid—epilepsy syndrome	5.83e-05	0.000303	CcSEcCtD
Eprosartan—Cough—Pregabalin—epilepsy syndrome	5.83e-05	0.000303	CcSEcCtD
Eprosartan—Pruritus—Phenytoin—epilepsy syndrome	5.82e-05	0.000302	CcSEcCtD
Eprosartan—Nausea—Levetiracetam—epilepsy syndrome	5.82e-05	0.000302	CcSEcCtD
Eprosartan—Rash—Vigabatrin—epilepsy syndrome	5.81e-05	0.000302	CcSEcCtD
Eprosartan—Dizziness—Felbamate—epilepsy syndrome	5.8e-05	0.000302	CcSEcCtD
Eprosartan—Dermatitis—Vigabatrin—epilepsy syndrome	5.8e-05	0.000302	CcSEcCtD
Eprosartan—Pruritus—Oxcarbazepine—epilepsy syndrome	5.79e-05	0.000301	CcSEcCtD
Eprosartan—Hypersensitivity—Carbamazepine—epilepsy syndrome	5.78e-05	0.000301	CcSEcCtD
Eprosartan—Headache—Vigabatrin—epilepsy syndrome	5.77e-05	0.0003	CcSEcCtD
Eprosartan—Vomiting—Diazepam—epilepsy syndrome	5.77e-05	0.0003	CcSEcCtD
Eprosartan—Anorexia—Valproic Acid—epilepsy syndrome	5.75e-05	0.000299	CcSEcCtD
Eprosartan—Tremor—Gabapentin—epilepsy syndrome	5.74e-05	0.000298	CcSEcCtD
Eprosartan—Rash—Diazepam—epilepsy syndrome	5.72e-05	0.000297	CcSEcCtD
Eprosartan—Dermatitis—Diazepam—epilepsy syndrome	5.71e-05	0.000297	CcSEcCtD
Eprosartan—Visual impairment—Topiramate—epilepsy syndrome	5.7e-05	0.000296	CcSEcCtD
Eprosartan—Arthralgia—Pregabalin—epilepsy syndrome	5.69e-05	0.000295	CcSEcCtD
Eprosartan—Myalgia—Pregabalin—epilepsy syndrome	5.69e-05	0.000295	CcSEcCtD
Eprosartan—Chest pain—Pregabalin—epilepsy syndrome	5.69e-05	0.000295	CcSEcCtD
Eprosartan—Ill-defined disorder—Gabapentin—epilepsy syndrome	5.68e-05	0.000295	CcSEcCtD
Eprosartan—Dizziness—Zonisamide—epilepsy syndrome	5.68e-05	0.000295	CcSEcCtD
Eprosartan—Headache—Diazepam—epilepsy syndrome	5.68e-05	0.000295	CcSEcCtD
Eprosartan—Anxiety—Pregabalin—epilepsy syndrome	5.67e-05	0.000294	CcSEcCtD
Eprosartan—Diarrhoea—Clonazepam—epilepsy syndrome	5.67e-05	0.000294	CcSEcCtD
Eprosartan—Hypotension—Valproic Acid—epilepsy syndrome	5.63e-05	0.000293	CcSEcCtD
Eprosartan—Asthenia—Carbamazepine—epilepsy syndrome	5.63e-05	0.000293	CcSEcCtD
Eprosartan—Diarrhoea—Phenytoin—epilepsy syndrome	5.63e-05	0.000292	CcSEcCtD
Eprosartan—Discomfort—Pregabalin—epilepsy syndrome	5.62e-05	0.000292	CcSEcCtD
Eprosartan—Nausea—Fosphenytoin—epilepsy syndrome	5.61e-05	0.000292	CcSEcCtD
Eprosartan—Diarrhoea—Oxcarbazepine—epilepsy syndrome	5.6e-05	0.000291	CcSEcCtD
Eprosartan—Angioedema—Gabapentin—epilepsy syndrome	5.6e-05	0.000291	CcSEcCtD
Eprosartan—Hypersensitivity—Lamotrigine—epilepsy syndrome	5.59e-05	0.00029	CcSEcCtD
Eprosartan—Vomiting—Felbamate—epilepsy syndrome	5.58e-05	0.00029	CcSEcCtD
Eprosartan—Dry mouth—Pregabalin—epilepsy syndrome	5.56e-05	0.000289	CcSEcCtD
Eprosartan—Pruritus—Carbamazepine—epilepsy syndrome	5.56e-05	0.000289	CcSEcCtD
Eprosartan—Rash—Felbamate—epilepsy syndrome	5.53e-05	0.000288	CcSEcCtD
Eprosartan—Dermatitis—Felbamate—epilepsy syndrome	5.53e-05	0.000287	CcSEcCtD
Eprosartan—Malaise—Gabapentin—epilepsy syndrome	5.52e-05	0.000287	CcSEcCtD
Eprosartan—Tinnitus—Topiramate—epilepsy syndrome	5.52e-05	0.000287	CcSEcCtD
Eprosartan—Vertigo—Gabapentin—epilepsy syndrome	5.5e-05	0.000286	CcSEcCtD
Eprosartan—Headache—Felbamate—epilepsy syndrome	5.5e-05	0.000286	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	5.49e-05	0.000285	CcSEcCtD
Eprosartan—Syncope—Gabapentin—epilepsy syndrome	5.49e-05	0.000285	CcSEcCtD
Eprosartan—Dizziness—Clonazepam—epilepsy syndrome	5.48e-05	0.000285	CcSEcCtD
Eprosartan—Nausea—Vigabatrin—epilepsy syndrome	5.47e-05	0.000284	CcSEcCtD
Eprosartan—Vomiting—Zonisamide—epilepsy syndrome	5.46e-05	0.000284	CcSEcCtD
Eprosartan—Insomnia—Valproic Acid—epilepsy syndrome	5.45e-05	0.000283	CcSEcCtD
Eprosartan—Asthenia—Lamotrigine—epilepsy syndrome	5.44e-05	0.000283	CcSEcCtD
Eprosartan—Dizziness—Phenytoin—epilepsy syndrome	5.44e-05	0.000283	CcSEcCtD
Eprosartan—Rash—Zonisamide—epilepsy syndrome	5.42e-05	0.000281	CcSEcCtD
Eprosartan—Paraesthesia—Valproic Acid—epilepsy syndrome	5.41e-05	0.000281	CcSEcCtD
Eprosartan—Palpitations—Gabapentin—epilepsy syndrome	5.41e-05	0.000281	CcSEcCtD
Eprosartan—Dermatitis—Zonisamide—epilepsy syndrome	5.41e-05	0.000281	CcSEcCtD
Eprosartan—Dizziness—Oxcarbazepine—epilepsy syndrome	5.41e-05	0.000281	CcSEcCtD
Eprosartan—Nausea—Diazepam—epilepsy syndrome	5.39e-05	0.00028	CcSEcCtD
Eprosartan—Loss of consciousness—Gabapentin—epilepsy syndrome	5.38e-05	0.00028	CcSEcCtD
Eprosartan—Headache—Zonisamide—epilepsy syndrome	5.38e-05	0.00028	CcSEcCtD
Eprosartan—Dyspnoea—Valproic Acid—epilepsy syndrome	5.38e-05	0.000279	CcSEcCtD
Eprosartan—Diarrhoea—Carbamazepine—epilepsy syndrome	5.37e-05	0.000279	CcSEcCtD
Eprosartan—Pruritus—Lamotrigine—epilepsy syndrome	5.37e-05	0.000279	CcSEcCtD
Eprosartan—Shock—Pregabalin—epilepsy syndrome	5.36e-05	0.000279	CcSEcCtD
Eprosartan—Somnolence—Valproic Acid—epilepsy syndrome	5.36e-05	0.000279	CcSEcCtD
Eprosartan—Cough—Gabapentin—epilepsy syndrome	5.34e-05	0.000278	CcSEcCtD
Eprosartan—Thrombocytopenia—Pregabalin—epilepsy syndrome	5.34e-05	0.000277	CcSEcCtD
Eprosartan—Tachycardia—Pregabalin—epilepsy syndrome	5.32e-05	0.000276	CcSEcCtD
Eprosartan—Chills—Topiramate—epilepsy syndrome	5.31e-05	0.000276	CcSEcCtD
Eprosartan—Dyspepsia—Valproic Acid—epilepsy syndrome	5.31e-05	0.000276	CcSEcCtD
Eprosartan—Hyperhidrosis—Pregabalin—epilepsy syndrome	5.27e-05	0.000274	CcSEcCtD
Eprosartan—Vomiting—Clonazepam—epilepsy syndrome	5.27e-05	0.000274	CcSEcCtD
Eprosartan—Decreased appetite—Valproic Acid—epilepsy syndrome	5.24e-05	0.000272	CcSEcCtD
Eprosartan—Vomiting—Phenytoin—epilepsy syndrome	5.23e-05	0.000272	CcSEcCtD
Eprosartan—Rash—Clonazepam—epilepsy syndrome	5.22e-05	0.000271	CcSEcCtD
Eprosartan—Dermatitis—Clonazepam—epilepsy syndrome	5.22e-05	0.000271	CcSEcCtD
Eprosartan—Chest pain—Gabapentin—epilepsy syndrome	5.21e-05	0.000271	CcSEcCtD
Eprosartan—Myalgia—Gabapentin—epilepsy syndrome	5.21e-05	0.000271	CcSEcCtD
Eprosartan—Arthralgia—Gabapentin—epilepsy syndrome	5.21e-05	0.000271	CcSEcCtD
Eprosartan—Nausea—Felbamate—epilepsy syndrome	5.21e-05	0.000271	CcSEcCtD
Eprosartan—Vomiting—Oxcarbazepine—epilepsy syndrome	5.2e-05	0.00027	CcSEcCtD
Eprosartan—Fatigue—Valproic Acid—epilepsy syndrome	5.2e-05	0.00027	CcSEcCtD
Eprosartan—Anxiety—Gabapentin—epilepsy syndrome	5.2e-05	0.00027	CcSEcCtD
Eprosartan—Anorexia—Pregabalin—epilepsy syndrome	5.2e-05	0.00027	CcSEcCtD
Eprosartan—Dizziness—Carbamazepine—epilepsy syndrome	5.19e-05	0.00027	CcSEcCtD
Eprosartan—Diarrhoea—Lamotrigine—epilepsy syndrome	5.19e-05	0.00027	CcSEcCtD
Eprosartan—Headache—Clonazepam—epilepsy syndrome	5.19e-05	0.00027	CcSEcCtD
Eprosartan—Rash—Phenytoin—epilepsy syndrome	5.19e-05	0.000269	CcSEcCtD
Eprosartan—Dermatitis—Phenytoin—epilepsy syndrome	5.18e-05	0.000269	CcSEcCtD
Eprosartan—Rash—Oxcarbazepine—epilepsy syndrome	5.16e-05	0.000268	CcSEcCtD
Eprosartan—Constipation—Valproic Acid—epilepsy syndrome	5.16e-05	0.000268	CcSEcCtD
Eprosartan—Pain—Valproic Acid—epilepsy syndrome	5.16e-05	0.000268	CcSEcCtD
Eprosartan—Dermatitis—Oxcarbazepine—epilepsy syndrome	5.15e-05	0.000268	CcSEcCtD
Eprosartan—Headache—Phenytoin—epilepsy syndrome	5.15e-05	0.000268	CcSEcCtD
Eprosartan—Discomfort—Gabapentin—epilepsy syndrome	5.15e-05	0.000268	CcSEcCtD
Eprosartan—Headache—Oxcarbazepine—epilepsy syndrome	5.13e-05	0.000266	CcSEcCtD
Eprosartan—Nausea—Zonisamide—epilepsy syndrome	5.1e-05	0.000265	CcSEcCtD
Eprosartan—Dry mouth—Gabapentin—epilepsy syndrome	5.1e-05	0.000265	CcSEcCtD
Eprosartan—Hypotension—Pregabalin—epilepsy syndrome	5.09e-05	0.000265	CcSEcCtD
Eprosartan—Flatulence—Topiramate—epilepsy syndrome	5.08e-05	0.000264	CcSEcCtD
Eprosartan—Tension—Topiramate—epilepsy syndrome	5.06e-05	0.000263	CcSEcCtD
Eprosartan—ABCC2—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	5.05e-05	0.000826	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—GAL—epilepsy syndrome	5.04e-05	0.000824	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—GABBR1—epilepsy syndrome	5.02e-05	0.000821	CbGpPWpGaD
Eprosartan—Dizziness—Lamotrigine—epilepsy syndrome	5.02e-05	0.000261	CcSEcCtD
Eprosartan—Nervousness—Topiramate—epilepsy syndrome	5e-05	0.00026	CcSEcCtD
Eprosartan—Vomiting—Carbamazepine—epilepsy syndrome	4.99e-05	0.000259	CcSEcCtD
Eprosartan—Back pain—Topiramate—epilepsy syndrome	4.98e-05	0.000259	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—GRM5—epilepsy syndrome	4.98e-05	0.000815	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CHRM3—epilepsy syndrome	4.98e-05	0.000815	CbGpPWpGaD
Eprosartan—Feeling abnormal—Valproic Acid—epilepsy syndrome	4.97e-05	0.000258	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	4.97e-05	0.000258	CcSEcCtD
Eprosartan—Muscle spasms—Topiramate—epilepsy syndrome	4.95e-05	0.000257	CcSEcCtD
Eprosartan—Rash—Carbamazepine—epilepsy syndrome	4.95e-05	0.000257	CcSEcCtD
Eprosartan—Dermatitis—Carbamazepine—epilepsy syndrome	4.95e-05	0.000257	CcSEcCtD
Eprosartan—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	4.93e-05	0.000256	CcSEcCtD
Eprosartan—Insomnia—Pregabalin—epilepsy syndrome	4.93e-05	0.000256	CcSEcCtD
Eprosartan—Nausea—Clonazepam—epilepsy syndrome	4.92e-05	0.000256	CcSEcCtD
Eprosartan—Headache—Carbamazepine—epilepsy syndrome	4.92e-05	0.000256	CcSEcCtD
Eprosartan—Shock—Gabapentin—epilepsy syndrome	4.92e-05	0.000256	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—CCR10—epilepsy syndrome	4.91e-05	0.000804	CbGpPWpGaD
Eprosartan—Paraesthesia—Pregabalin—epilepsy syndrome	4.9e-05	0.000254	CcSEcCtD
Eprosartan—Thrombocytopenia—Gabapentin—epilepsy syndrome	4.89e-05	0.000254	CcSEcCtD
Eprosartan—Nausea—Phenytoin—epilepsy syndrome	4.89e-05	0.000254	CcSEcCtD
Eprosartan—Tachycardia—Gabapentin—epilepsy syndrome	4.88e-05	0.000253	CcSEcCtD
Eprosartan—Dyspnoea—Pregabalin—epilepsy syndrome	4.86e-05	0.000253	CcSEcCtD
Eprosartan—Nausea—Oxcarbazepine—epilepsy syndrome	4.86e-05	0.000253	CcSEcCtD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	4.86e-05	0.000795	CbGpPWpGaD
Eprosartan—Somnolence—Pregabalin—epilepsy syndrome	4.85e-05	0.000252	CcSEcCtD
Eprosartan—Hyperhidrosis—Gabapentin—epilepsy syndrome	4.83e-05	0.000251	CcSEcCtD
Eprosartan—Tremor—Topiramate—epilepsy syndrome	4.83e-05	0.000251	CcSEcCtD
Eprosartan—Vomiting—Lamotrigine—epilepsy syndrome	4.82e-05	0.000251	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—HRH3—epilepsy syndrome	4.81e-05	0.000787	CbGpPWpGaD
Eprosartan—Urticaria—Valproic Acid—epilepsy syndrome	4.79e-05	0.000249	CcSEcCtD
Eprosartan—Rash—Lamotrigine—epilepsy syndrome	4.78e-05	0.000249	CcSEcCtD
Eprosartan—Ill-defined disorder—Topiramate—epilepsy syndrome	4.78e-05	0.000248	CcSEcCtD
Eprosartan—Dermatitis—Lamotrigine—epilepsy syndrome	4.78e-05	0.000248	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—CX3CR1—epilepsy syndrome	4.78e-05	0.000781	CbGpPWpGaD
Eprosartan—Body temperature increased—Valproic Acid—epilepsy syndrome	4.77e-05	0.000248	CcSEcCtD
Eprosartan—Abdominal pain—Valproic Acid—epilepsy syndrome	4.77e-05	0.000248	CcSEcCtD
Eprosartan—Anorexia—Gabapentin—epilepsy syndrome	4.77e-05	0.000248	CcSEcCtD
Eprosartan—Headache—Lamotrigine—epilepsy syndrome	4.75e-05	0.000247	CcSEcCtD
Eprosartan—Decreased appetite—Pregabalin—epilepsy syndrome	4.74e-05	0.000246	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—OPRM1—epilepsy syndrome	4.74e-05	0.000775	CbGpPWpGaD
Eprosartan—Fatigue—Pregabalin—epilepsy syndrome	4.7e-05	0.000244	CcSEcCtD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	4.69e-05	0.000767	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	4.69e-05	0.000767	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—BDKRB1—epilepsy syndrome	4.68e-05	0.000766	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CHRM2—epilepsy syndrome	4.68e-05	0.000766	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CX3CL1—epilepsy syndrome	4.68e-05	0.000766	CbGpPWpGaD
Eprosartan—Hypotension—Gabapentin—epilepsy syndrome	4.67e-05	0.000243	CcSEcCtD
Eprosartan—Nausea—Carbamazepine—epilepsy syndrome	4.66e-05	0.000242	CcSEcCtD
Eprosartan—Constipation—Pregabalin—epilepsy syndrome	4.66e-05	0.000242	CcSEcCtD
Eprosartan—Pain—Pregabalin—epilepsy syndrome	4.66e-05	0.000242	CcSEcCtD
Eprosartan—Malaise—Topiramate—epilepsy syndrome	4.65e-05	0.000241	CcSEcCtD
Eprosartan—Vertigo—Topiramate—epilepsy syndrome	4.63e-05	0.000241	CcSEcCtD
Eprosartan—Syncope—Topiramate—epilepsy syndrome	4.62e-05	0.00024	CcSEcCtD
Eprosartan—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	4.58e-05	0.000748	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—GABBR1—epilepsy syndrome	4.56e-05	0.000746	CbGpPWpGaD
Eprosartan—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	4.55e-05	0.000237	CcSEcCtD
Eprosartan—Palpitations—Topiramate—epilepsy syndrome	4.55e-05	0.000237	CcSEcCtD
Eprosartan—Loss of consciousness—Topiramate—epilepsy syndrome	4.53e-05	0.000235	CcSEcCtD
Eprosartan—Insomnia—Gabapentin—epilepsy syndrome	4.52e-05	0.000235	CcSEcCtD
Eprosartan—Nausea—Lamotrigine—epilepsy syndrome	4.51e-05	0.000234	CcSEcCtD
Eprosartan—Cough—Topiramate—epilepsy syndrome	4.5e-05	0.000234	CcSEcCtD
Eprosartan—Feeling abnormal—Pregabalin—epilepsy syndrome	4.49e-05	0.000233	CcSEcCtD
Eprosartan—Paraesthesia—Gabapentin—epilepsy syndrome	4.49e-05	0.000233	CcSEcCtD
Eprosartan—CYP2C9—Biological oxidations—CYP2C19—epilepsy syndrome	4.48e-05	0.000733	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CCR3—epilepsy syndrome	4.47e-05	0.000732	CbGpPWpGaD
Eprosartan—Gastrointestinal pain—Pregabalin—epilepsy syndrome	4.46e-05	0.000232	CcSEcCtD
Eprosartan—Dyspnoea—Gabapentin—epilepsy syndrome	4.46e-05	0.000232	CcSEcCtD
Eprosartan—CYP2C9—Biological oxidations—CYP11A1—epilepsy syndrome	4.46e-05	0.000729	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—POMC—epilepsy syndrome	4.45e-05	0.000728	CbGpPWpGaD
Eprosartan—Somnolence—Gabapentin—epilepsy syndrome	4.44e-05	0.000231	CcSEcCtD
Eprosartan—Hypersensitivity—Valproic Acid—epilepsy syndrome	4.44e-05	0.000231	CcSEcCtD
Eprosartan—CYP2C9—Metapathway biotransformation—CYP2C19—epilepsy syndrome	4.42e-05	0.000723	CbGpPWpGaD
Eprosartan—Dyspepsia—Gabapentin—epilepsy syndrome	4.4e-05	0.000229	CcSEcCtD
Eprosartan—CYP2C9—Metapathway biotransformation—CYP11A1—epilepsy syndrome	4.39e-05	0.000719	CbGpPWpGaD
Eprosartan—Arthralgia—Topiramate—epilepsy syndrome	4.39e-05	0.000228	CcSEcCtD
Eprosartan—Chest pain—Topiramate—epilepsy syndrome	4.39e-05	0.000228	CcSEcCtD
Eprosartan—Myalgia—Topiramate—epilepsy syndrome	4.39e-05	0.000228	CcSEcCtD
Eprosartan—Anxiety—Topiramate—epilepsy syndrome	4.37e-05	0.000227	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—HRH3—epilepsy syndrome	4.37e-05	0.000715	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—NPY—epilepsy syndrome	4.36e-05	0.000713	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—epilepsy syndrome	4.36e-05	0.000712	CbGpPWpGaD
Eprosartan—Decreased appetite—Gabapentin—epilepsy syndrome	4.35e-05	0.000226	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—CCR5—epilepsy syndrome	4.34e-05	0.000709	CbGpPWpGaD
Eprosartan—Discomfort—Topiramate—epilepsy syndrome	4.33e-05	0.000225	CcSEcCtD
Eprosartan—Urticaria—Pregabalin—epilepsy syndrome	4.33e-05	0.000225	CcSEcCtD
Eprosartan—Asthenia—Valproic Acid—epilepsy syndrome	4.33e-05	0.000225	CcSEcCtD
Eprosartan—Fatigue—Gabapentin—epilepsy syndrome	4.31e-05	0.000224	CcSEcCtD
Eprosartan—Abdominal pain—Pregabalin—epilepsy syndrome	4.31e-05	0.000224	CcSEcCtD
Eprosartan—Body temperature increased—Pregabalin—epilepsy syndrome	4.31e-05	0.000224	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—OPRM1—epilepsy syndrome	4.3e-05	0.000704	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GRM2—epilepsy syndrome	4.29e-05	0.000703	CbGpPWpGaD
Eprosartan—Dry mouth—Topiramate—epilepsy syndrome	4.29e-05	0.000223	CcSEcCtD
Eprosartan—Pain—Gabapentin—epilepsy syndrome	4.27e-05	0.000222	CcSEcCtD
Eprosartan—Constipation—Gabapentin—epilepsy syndrome	4.27e-05	0.000222	CcSEcCtD
Eprosartan—Pruritus—Valproic Acid—epilepsy syndrome	4.27e-05	0.000222	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—HTR2A—epilepsy syndrome	4.24e-05	0.000694	CbGpPWpGaD
Eprosartan—CYP2C9—Arachidonic acid metabolism—PTGS2—epilepsy syndrome	4.22e-05	0.000691	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CRH—epilepsy syndrome	4.21e-05	0.000688	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—OXT—epilepsy syndrome	4.21e-05	0.000688	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CXCL2—epilepsy syndrome	4.21e-05	0.000688	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	4.18e-05	0.000684	CbGpPWpGaD
Eprosartan—Shock—Topiramate—epilepsy syndrome	4.14e-05	0.000215	CcSEcCtD
Eprosartan—Diarrhoea—Valproic Acid—epilepsy syndrome	4.13e-05	0.000214	CcSEcCtD
Eprosartan—Feeling abnormal—Gabapentin—epilepsy syndrome	4.12e-05	0.000214	CcSEcCtD
Eprosartan—Thrombocytopenia—Topiramate—epilepsy syndrome	4.12e-05	0.000214	CcSEcCtD
Eprosartan—Tachycardia—Topiramate—epilepsy syndrome	4.1e-05	0.000213	CcSEcCtD
Eprosartan—Gastrointestinal pain—Gabapentin—epilepsy syndrome	4.09e-05	0.000212	CcSEcCtD
Eprosartan—Hyperhidrosis—Topiramate—epilepsy syndrome	4.07e-05	0.000211	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—CCR3—epilepsy syndrome	4.06e-05	0.000664	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—AGT—epilepsy syndrome	4.03e-05	0.000659	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—CYP2D6—epilepsy syndrome	4.02e-05	0.000658	CbGpPWpGaD
Eprosartan—Hypersensitivity—Pregabalin—epilepsy syndrome	4.02e-05	0.000209	CcSEcCtD
Eprosartan—Anorexia—Topiramate—epilepsy syndrome	4.01e-05	0.000208	CcSEcCtD
Eprosartan—Dizziness—Valproic Acid—epilepsy syndrome	3.99e-05	0.000207	CcSEcCtD
Eprosartan—Urticaria—Gabapentin—epilepsy syndrome	3.97e-05	0.000206	CcSEcCtD
Eprosartan—CYP2C9—Metapathway biotransformation—CYP2D6—epilepsy syndrome	3.97e-05	0.000649	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—NPY—epilepsy syndrome	3.96e-05	0.000648	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	3.96e-05	0.000647	CbGpPWpGaD
Eprosartan—Abdominal pain—Gabapentin—epilepsy syndrome	3.95e-05	0.000205	CcSEcCtD
Eprosartan—Body temperature increased—Gabapentin—epilepsy syndrome	3.95e-05	0.000205	CcSEcCtD
Eprosartan—Hypotension—Topiramate—epilepsy syndrome	3.93e-05	0.000204	CcSEcCtD
Eprosartan—Asthenia—Pregabalin—epilepsy syndrome	3.91e-05	0.000203	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—SSTR3—epilepsy syndrome	3.88e-05	0.000635	CbGpPWpGaD
Eprosartan—Pruritus—Pregabalin—epilepsy syndrome	3.86e-05	0.0002	CcSEcCtD
Eprosartan—Vomiting—Valproic Acid—epilepsy syndrome	3.83e-05	0.000199	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	3.83e-05	0.000199	CcSEcCtD
Eprosartan—ABCC2—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	3.82e-05	0.000626	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—OXT—epilepsy syndrome	3.82e-05	0.000625	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CRH—epilepsy syndrome	3.82e-05	0.000625	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CXCL2—epilepsy syndrome	3.82e-05	0.000625	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCL3—epilepsy syndrome	3.82e-05	0.000625	CbGpPWpGaD
Eprosartan—Insomnia—Topiramate—epilepsy syndrome	3.8e-05	0.000198	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—CCR2—epilepsy syndrome	3.8e-05	0.000622	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—SST—epilepsy syndrome	3.8e-05	0.000622	CbGpPWpGaD
Eprosartan—Rash—Valproic Acid—epilepsy syndrome	3.8e-05	0.000198	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—ST3GAL3—epilepsy syndrome	3.8e-05	0.000622	CbGpPWpGaD
Eprosartan—Dermatitis—Valproic Acid—epilepsy syndrome	3.8e-05	0.000197	CcSEcCtD
Eprosartan—Headache—Valproic Acid—epilepsy syndrome	3.78e-05	0.000196	CcSEcCtD
Eprosartan—Paraesthesia—Topiramate—epilepsy syndrome	3.78e-05	0.000196	CcSEcCtD
Eprosartan—Dyspnoea—Topiramate—epilepsy syndrome	3.75e-05	0.000195	CcSEcCtD
Eprosartan—Somnolence—Topiramate—epilepsy syndrome	3.74e-05	0.000194	CcSEcCtD
Eprosartan—Diarrhoea—Pregabalin—epilepsy syndrome	3.73e-05	0.000194	CcSEcCtD
Eprosartan—ABCC2—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	3.73e-05	0.00061	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ARHGEF9—epilepsy syndrome	3.72e-05	0.000609	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCR8—epilepsy syndrome	3.72e-05	0.000609	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SSTR1—epilepsy syndrome	3.72e-05	0.000609	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCR9—epilepsy syndrome	3.72e-05	0.000609	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NPY2R—epilepsy syndrome	3.72e-05	0.000609	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—ADRA2A—epilepsy syndrome	3.72e-05	0.000609	CbGpPWpGaD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	3.71e-05	0.000607	CbGpPWpGaD
Eprosartan—Dyspepsia—Topiramate—epilepsy syndrome	3.7e-05	0.000192	CcSEcCtD
Eprosartan—Hypersensitivity—Gabapentin—epilepsy syndrome	3.68e-05	0.000191	CcSEcCtD
Eprosartan—Decreased appetite—Topiramate—epilepsy syndrome	3.66e-05	0.00019	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—GRM4—epilepsy syndrome	3.65e-05	0.000597	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GRM3—epilepsy syndrome	3.65e-05	0.000597	CbGpPWpGaD
Eprosartan—Fatigue—Topiramate—epilepsy syndrome	3.63e-05	0.000188	CcSEcCtD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	3.62e-05	0.000592	CbGpPWpGaD
Eprosartan—Dizziness—Pregabalin—epilepsy syndrome	3.6e-05	0.000187	CcSEcCtD
Eprosartan—Pain—Topiramate—epilepsy syndrome	3.6e-05	0.000187	CcSEcCtD
Eprosartan—Constipation—Topiramate—epilepsy syndrome	3.6e-05	0.000187	CcSEcCtD
Eprosartan—Asthenia—Gabapentin—epilepsy syndrome	3.59e-05	0.000186	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—DUSP4—epilepsy syndrome	3.58e-05	0.000586	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SSTR2—epilepsy syndrome	3.58e-05	0.000586	CbGpPWpGaD
Eprosartan—Nausea—Valproic Acid—epilepsy syndrome	3.58e-05	0.000186	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—BDKRB2—epilepsy syndrome	3.58e-05	0.000585	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CXCL12—epilepsy syndrome	3.58e-05	0.000585	CbGpPWpGaD
Eprosartan—Pruritus—Gabapentin—epilepsy syndrome	3.54e-05	0.000184	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—CNR1—epilepsy syndrome	3.51e-05	0.000574	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—PLCB1—epilepsy syndrome	3.5e-05	0.000572	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	3.48e-05	0.00057	CbGpPWpGaD
Eprosartan—Vomiting—Pregabalin—epilepsy syndrome	3.47e-05	0.00018	CcSEcCtD
Eprosartan—Feeling abnormal—Topiramate—epilepsy syndrome	3.47e-05	0.00018	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—GRM8—epilepsy syndrome	3.46e-05	0.000566	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PGF—epilepsy syndrome	3.46e-05	0.000566	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—SST—epilepsy syndrome	3.45e-05	0.000565	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCR2—epilepsy syndrome	3.45e-05	0.000565	CbGpPWpGaD
Eprosartan—Gastrointestinal pain—Topiramate—epilepsy syndrome	3.44e-05	0.000179	CcSEcCtD
Eprosartan—Rash—Pregabalin—epilepsy syndrome	3.44e-05	0.000179	CcSEcCtD
Eprosartan—Dermatitis—Pregabalin—epilepsy syndrome	3.43e-05	0.000178	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—HTR7—epilepsy syndrome	3.42e-05	0.00056	CbGpPWpGaD
Eprosartan—Diarrhoea—Gabapentin—epilepsy syndrome	3.42e-05	0.000178	CcSEcCtD
Eprosartan—Headache—Pregabalin—epilepsy syndrome	3.42e-05	0.000177	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—POMC—epilepsy syndrome	3.39e-05	0.000554	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—ADRA2A—epilepsy syndrome	3.38e-05	0.000553	CbGpPWpGaD
Eprosartan—Urticaria—Topiramate—epilepsy syndrome	3.34e-05	0.000174	CcSEcCtD
Eprosartan—Body temperature increased—Topiramate—epilepsy syndrome	3.32e-05	0.000173	CcSEcCtD
Eprosartan—Abdominal pain—Topiramate—epilepsy syndrome	3.32e-05	0.000173	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—CCL2—epilepsy syndrome	3.32e-05	0.000543	CbGpPWpGaD
Eprosartan—Dizziness—Gabapentin—epilepsy syndrome	3.31e-05	0.000172	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—GNAO1—epilepsy syndrome	3.3e-05	0.00054	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—OPRD1—epilepsy syndrome	3.3e-05	0.00054	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—AKT3—epilepsy syndrome	3.26e-05	0.000534	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CXCL12—epilepsy syndrome	3.25e-05	0.000531	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—BDKRB2—epilepsy syndrome	3.25e-05	0.000531	CbGpPWpGaD
Eprosartan—Nausea—Pregabalin—epilepsy syndrome	3.24e-05	0.000168	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—CNR1—epilepsy syndrome	3.19e-05	0.000521	CbGpPWpGaD
Eprosartan—Vomiting—Gabapentin—epilepsy syndrome	3.18e-05	0.000165	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—PLCB1—epilepsy syndrome	3.18e-05	0.00052	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	3.17e-05	0.000518	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCR7—epilepsy syndrome	3.17e-05	0.000518	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CHRM1—epilepsy syndrome	3.17e-05	0.000518	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PDYN—epilepsy syndrome	3.17e-05	0.000518	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GRM1—epilepsy syndrome	3.17e-05	0.000518	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	3.16e-05	0.000517	CbGpPWpGaD
Eprosartan—Rash—Gabapentin—epilepsy syndrome	3.15e-05	0.000164	CcSEcCtD
Eprosartan—Dermatitis—Gabapentin—epilepsy syndrome	3.15e-05	0.000164	CcSEcCtD
Eprosartan—Headache—Gabapentin—epilepsy syndrome	3.13e-05	0.000163	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—HTR7—epilepsy syndrome	3.11e-05	0.000509	CbGpPWpGaD
Eprosartan—Hypersensitivity—Topiramate—epilepsy syndrome	3.1e-05	0.000161	CcSEcCtD
Eprosartan—CYP2C9—Metabolism—CA13—epilepsy syndrome	3.07e-05	0.000502	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	3.02e-05	0.000495	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—HBEGF—epilepsy syndrome	3.02e-05	0.000494	CbGpPWpGaD
Eprosartan—Asthenia—Topiramate—epilepsy syndrome	3.02e-05	0.000157	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—CDC42—epilepsy syndrome	2.98e-05	0.000487	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GFAP—epilepsy syndrome	2.98e-05	0.000487	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GAL—epilepsy syndrome	2.98e-05	0.000487	CbGpPWpGaD
Eprosartan—Pruritus—Topiramate—epilepsy syndrome	2.98e-05	0.000155	CcSEcCtD
Eprosartan—Nausea—Gabapentin—epilepsy syndrome	2.97e-05	0.000154	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—AKT3—epilepsy syndrome	2.96e-05	0.000485	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CASP2—epilepsy syndrome	2.94e-05	0.000482	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GRM5—epilepsy syndrome	2.94e-05	0.000482	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CHRM3—epilepsy syndrome	2.94e-05	0.000482	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—AVP—epilepsy syndrome	2.88e-05	0.000472	CbGpPWpGaD
Eprosartan—Diarrhoea—Topiramate—epilepsy syndrome	2.88e-05	0.00015	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—CX3CR1—epilepsy syndrome	2.82e-05	0.000462	CbGpPWpGaD
Eprosartan—Dizziness—Topiramate—epilepsy syndrome	2.78e-05	0.000144	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—CHRM2—epilepsy syndrome	2.77e-05	0.000453	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—BDKRB1—epilepsy syndrome	2.77e-05	0.000453	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CX3CL1—epilepsy syndrome	2.77e-05	0.000453	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CDC42—epilepsy syndrome	2.7e-05	0.000442	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GABBR1—epilepsy syndrome	2.69e-05	0.00044	CbGpPWpGaD
Eprosartan—Vomiting—Topiramate—epilepsy syndrome	2.67e-05	0.000139	CcSEcCtD
Eprosartan—Rash—Topiramate—epilepsy syndrome	2.65e-05	0.000138	CcSEcCtD
Eprosartan—Dermatitis—Topiramate—epilepsy syndrome	2.65e-05	0.000138	CcSEcCtD
Eprosartan—Headache—Topiramate—epilepsy syndrome	2.63e-05	0.000137	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—AVP—epilepsy syndrome	2.62e-05	0.000428	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HRH3—epilepsy syndrome	2.58e-05	0.000422	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—OPRM1—epilepsy syndrome	2.54e-05	0.000416	CbGpPWpGaD
Eprosartan—Nausea—Topiramate—epilepsy syndrome	2.5e-05	0.00013	CcSEcCtD
Eprosartan—ABCC2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.49e-05	0.000407	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	2.47e-05	0.000404	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.46e-05	0.000403	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CCR5—epilepsy syndrome	2.45e-05	0.000401	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCR3—epilepsy syndrome	2.4e-05	0.000393	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—HTR2A—epilepsy syndrome	2.4e-05	0.000392	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.39e-05	0.00039	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NPY—epilepsy syndrome	2.34e-05	0.000383	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ATP2A2—epilepsy syndrome	2.34e-05	0.000383	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ADK—epilepsy syndrome	2.32e-05	0.00038	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—FAR1—epilepsy syndrome	2.32e-05	0.00038	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PDXK—epilepsy syndrome	2.32e-05	0.00038	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—L2HGDH—epilepsy syndrome	2.32e-05	0.00038	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CERS1—epilepsy syndrome	2.32e-05	0.00038	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GLUD1—epilepsy syndrome	2.32e-05	0.00038	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—AGT—epilepsy syndrome	2.28e-05	0.000372	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HSPB1—epilepsy syndrome	2.26e-05	0.000369	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCL3—epilepsy syndrome	2.26e-05	0.000369	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CXCL2—epilepsy syndrome	2.26e-05	0.000369	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—OXT—epilepsy syndrome	2.26e-05	0.000369	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CRH—epilepsy syndrome	2.26e-05	0.000369	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCR5—epilepsy syndrome	2.23e-05	0.000364	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—HTR2A—epilepsy syndrome	2.18e-05	0.000356	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—NHLRC1—epilepsy syndrome	2.13e-05	0.000348	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GAMT—epilepsy syndrome	2.13e-05	0.000348	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—EPM2A—epilepsy syndrome	2.13e-05	0.000348	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PNPO—epilepsy syndrome	2.13e-05	0.000348	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—PRKCB—epilepsy syndrome	2.1e-05	0.000344	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TSC1—epilepsy syndrome	2.1e-05	0.000343	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PTK2B—epilepsy syndrome	2.1e-05	0.000343	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—AGT—epilepsy syndrome	2.07e-05	0.000338	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCR2—epilepsy syndrome	2.04e-05	0.000334	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SST—epilepsy syndrome	2.04e-05	0.000334	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NTRK2—epilepsy syndrome	2.04e-05	0.000334	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—DUSP6—epilepsy syndrome	2.02e-05	0.000331	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ADRA2A—epilepsy syndrome	2e-05	0.000327	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PLAT—epilepsy syndrome	1.99e-05	0.000325	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CA4—epilepsy syndrome	1.98e-05	0.000323	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—QDPR—epilepsy syndrome	1.98e-05	0.000323	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—POMC—epilepsy syndrome	1.97e-05	0.000322	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CXCL12—epilepsy syndrome	1.92e-05	0.000314	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.92e-05	0.000314	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—POMC—epilepsy syndrome	1.92e-05	0.000313	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.91e-05	0.000312	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.9e-05	0.000311	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—JUNB—epilepsy syndrome	1.88e-05	0.000308	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CNR1—epilepsy syndrome	1.88e-05	0.000308	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PLCB1—epilepsy syndrome	1.88e-05	0.000307	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—COX3—epilepsy syndrome	1.86e-05	0.000304	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HTR7—epilepsy syndrome	1.84e-05	0.000301	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HBEGF—epilepsy syndrome	1.78e-05	0.000292	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—KCNB1—epilepsy syndrome	1.76e-05	0.000288	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SLCO1A2—epilepsy syndrome	1.76e-05	0.000288	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PFKL—epilepsy syndrome	1.76e-05	0.000288	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CACNA2D2—epilepsy syndrome	1.76e-05	0.000288	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SLC6A8—epilepsy syndrome	1.76e-05	0.000288	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—AKT3—epilepsy syndrome	1.75e-05	0.000286	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—POMC—epilepsy syndrome	1.74e-05	0.000285	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.72e-05	0.000282	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.71e-05	0.00028	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ADAM10—epilepsy syndrome	1.71e-05	0.00028	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCL2—epilepsy syndrome	1.7e-05	0.000278	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—S100B—epilepsy syndrome	1.62e-05	0.000264	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—UPB1—epilepsy syndrome	1.61e-05	0.000264	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—NEU1—epilepsy syndrome	1.61e-05	0.000264	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ATIC—epilepsy syndrome	1.61e-05	0.000264	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SOCS3—epilepsy syndrome	1.6e-05	0.000262	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CDC42—epilepsy syndrome	1.6e-05	0.000261	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—HSD17B4—epilepsy syndrome	1.55e-05	0.000254	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—AVP—epilepsy syndrome	1.55e-05	0.000253	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	1.5e-05	0.000245	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GBE1—epilepsy syndrome	1.5e-05	0.000245	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.49e-05	0.000244	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.46e-05	0.000239	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HES1—epilepsy syndrome	1.46e-05	0.000239	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—FYN—epilepsy syndrome	1.42e-05	0.000233	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—H2AFX—epilepsy syndrome	1.42e-05	0.000232	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MEF2C—epilepsy syndrome	1.41e-05	0.000231	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	1.41e-05	0.00023	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	1.37e-05	0.000224	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.37e-05	0.000224	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NGF—epilepsy syndrome	1.35e-05	0.000221	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—NT5E—epilepsy syndrome	1.33e-05	0.000218	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ALAD—epilepsy syndrome	1.33e-05	0.000218	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCR5—epilepsy syndrome	1.31e-05	0.000215	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HTR2A—epilepsy syndrome	1.29e-05	0.00021	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	1.27e-05	0.000208	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	1.27e-05	0.000208	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	1.25e-05	0.000204	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TSC2—epilepsy syndrome	1.22e-05	0.0002	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ADSL—epilepsy syndrome	1.22e-05	0.0002	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—AGT—epilepsy syndrome	1.22e-05	0.0002	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GLUL—epilepsy syndrome	1.2e-05	0.000196	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—APOE—epilepsy syndrome	1.2e-05	0.000196	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	1.18e-05	0.000192	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—KDR—epilepsy syndrome	1.17e-05	0.000192	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PRKCB—epilepsy syndrome	1.13e-05	0.000185	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IL6ST—epilepsy syndrome	1.12e-05	0.000184	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	1.1e-05	0.00018	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—AQP1—epilepsy syndrome	1.07e-05	0.000175	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—POMC—epilepsy syndrome	1.03e-05	0.000168	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.03e-05	0.000168	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCL2—epilepsy syndrome	1.01e-05	0.000164	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	9.65e-06	0.000158	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	9.65e-06	0.000158	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—FGF2—epilepsy syndrome	9.09e-06	0.000149	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	8.99e-06	0.000147	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	8.81e-06	0.000144	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—RELA—epilepsy syndrome	8.43e-06	0.000138	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MTOR—epilepsy syndrome	8.27e-06	0.000135	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	7.87e-06	0.000129	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—AKT1—epilepsy syndrome	7.68e-06	0.000126	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	7.67e-06	0.000125	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	7.62e-06	0.000125	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CASP3—epilepsy syndrome	7.61e-06	0.000124	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	7.57e-06	0.000124	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—JUN—epilepsy syndrome	7.39e-06	0.000121	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MMP9—epilepsy syndrome	7.19e-06	0.000118	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—AKT1—epilepsy syndrome	6.97e-06	0.000114	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	6.9e-06	0.000113	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	6.88e-06	0.000112	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SRC—epilepsy syndrome	6.63e-06	0.000108	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	6.55e-06	0.000107	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—BCHE—epilepsy syndrome	6.52e-06	0.000107	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—VEGFA—epilepsy syndrome	6.46e-06	0.000106	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	6.22e-06	0.000102	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	6.15e-06	0.000101	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—TH—epilepsy syndrome	6.13e-06	0.0001	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	6.03e-06	9.87e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	5.12e-06	8.37e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CAT—epilepsy syndrome	5.05e-06	8.26e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	4.91e-06	8.03e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GPX1—epilepsy syndrome	4.56e-06	7.47e-05	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—AKT1—epilepsy syndrome	4.12e-06	6.74e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—AGT—epilepsy syndrome	4e-06	6.55e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—APOE—epilepsy syndrome	3.92e-06	6.42e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—POMC—epilepsy syndrome	3.37e-06	5.51e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ALB—epilepsy syndrome	3.07e-06	5.02e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	2.69e-06	4.4e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—AKT1—epilepsy syndrome	1.35e-06	2.21e-05	CbGpPWpGaD
